Pfizer (PFE) Free Cash Flow (2009 - 2025)
Pfizer (PFE) posted Free Cash Flow of $4.8 billion for Q3 2026, up 20.0% from $4 billion a year earlier.
Powered by 
Analysis
Pfizer (PFE) Free Cash Flow (2009 - 2025) Analysis & Trends
For the trailing twelve months through Sep 27, 2026, Free Cash Flow at Pfizer was $11.79 billion, up 13.6% year-over-year; for FY2025, it was $9.08 billion, down 7.7% from FY2024.
- Annual Free Cash Flow shows a five-year compound annual growth rate of -5.7% (FY2020 to FY2025).
- In prior years, Pfizer's Free Cash Flow was $9.84 billion in FY2024 (+105.2%), $4.79 billion in FY2023 (-81.6%), $26.03 billion in FY2022 (-13.8%) and $30.21 billion in FY2021 (+148.1%).
- The Q3 2026 figure stands as the highest quarterly Free Cash Flow since Q4 2024.
- On a year-over-year basis, Free Cash Flow increased in four of the last six quarters, with growth averaging 64.0%.
- The strongest year-over-year quarter for Free Cash Flow in the past five years was Q1 2024, with growth of 428.8%; the weakest was Q1 2023, with a decline of 98.8%.
- According to Business Quant data, Free Cash Flow for the three prior quarters was $302 million (Q2 2026), $2.18 billion (Q1 2026) and $4.5 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Yr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.97 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.70 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 17.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.36 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 17.60 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 11.77 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 8.10 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 9.46 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 9.08 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 3.19 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9.08 Bn |
| Dec 31, 2024 | 9.84 Bn |
| Dec 31, 2023 | 4.79 Bn |
| Dec 31, 2022 | 26.03 Bn |
| Dec 31, 2021 | 30.21 Bn |
| Dec 31, 2020 | 12.18 Bn |
| Dec 31, 2019 | 10.54 Bn |
| Dec 31, 2018 | 13.84 Bn |
| Dec 31, 2017 | 14.85 Bn |
| Dec 31, 2016 | 14.37 Bn |
| Dec 31, 2015 | 13.29 Bn |
| Dec 31, 2014 | 15.89 Bn |
| Dec 31, 2013 | 16.48 Bn |
| Dec 31, 2012 | 15.42 Bn |
| Dec 31, 2011 | 18.58 Bn |
| Dec 31, 2010 | 9.94 Bn |
| Dec 31, 2009 | 15.38 Bn |
API Access
Pfizer Free Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=free-cash-flow-annual&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "free-cash-flow-annual", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=free-cash-flow-annual&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();